Author
Eliezer Masliah
- Indexed works
- 26
- Total citations
- 17,643
- Active years
- 19
Collaborators
Works in the record
Alzheimer s & Dementia 2018
Open access · CC-BY
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Human Molecular Genetics 2010
Open access · OA
Molecular mechanisms of neurodegeneration in Alzheimer's disease
Proceedings of the National Academy of Sciences 2001
Preprint · OA
β-Amyloid peptides enhance α-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease
Journal of Neuroscience 2009
Open access · CC-BY
Beclin 1 Gene Transfer Activates Autophagy and Ameliorates the Neurodegenerative Pathology in α-Synuclein Models of Parkinson's and Lewy Body Diseases
Journal of Neuroscience 2004
Open access · CC-BY
Early and Progressive Sensorimotor Anomalies in Mice Overexpressing Wild-Type Human α-Synuclein
Proceedings of the National Academy of Sciences 2002
Preprint · OA
Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice
Cell 2013
Open access · OA
Isogenic Human iPSC Parkinson’s Model Shows Nitrosative Stress-Induced Dysfunction in MEF2-PGC1α Transcription
PLoS ONE 2011
Open access · CC-BY
Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease
Nature 1997
Citation only
Amyloidogenic role of cytokine TGF-β1 in transgenic mice and in Alzheimer's disease
Nature 2012
Preprint · OA
Increased proteasome activity in human embryonic stem cells is regulated by PSMD11
Journal of Clinical Investigation 2006
Open access · OA
Deficiency in neuronal TGF-β signaling promotes neurodegeneration and Alzheimer’s pathology
Proceedings of the National Academy of Sciences 2003
Preprint · OA
Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice
Journal of Neuroscience 2014
Open access · OA
Reducing C-Terminal-Truncated Alpha-Synuclein by Immunotherapy Attenuates Neurodegeneration and Propagation in Parkinson's Disease-Like Models
PLoS ONE 2008
Open access · CC0
Mechanisms of Hybrid Oligomer Formation in the Pathogenesis of Combined Alzheimer's and Parkinson's Diseases
Human Molecular Genetics 2014
Open access · OA
c-Abl phosphorylates α-synuclein and regulates its degradation: implication for α-synuclein clearance and contribution to the pathogenesis of Parkinson's disease
PubMed 1996
Preprint · OA
Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer's disease.
Scientific Reports 2018
Open access · CC-BY
The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson’s disease
Brain 2016
Open access · OA
A de novo compound targeting α-synuclein improves deficits in models of Parkinson's disease
Alzheimer s & Dementia 2016
Preprint · OA
Circadian alterations during early stages of Alzheimer's disease are associated with aberrant cycles of DNA methylation in BMAL1
Journal of NeuroVirology 2015
Preprint · OA
Accelerated epigenetic aging in brain is associated with pre-mortem HIV-associated neurocognitive disorders
Brain Structure and Function 2009
Open access · CC-BY
APP transgenic modeling of Alzheimer’s disease: mechanisms of neurodegeneration and aberrant neurogenesis
Neurobiology of Disease 2015
Preprint · OA
Severely impaired hippocampal neurogenesis associates with an early serotonergic deficit in a BAC α-synuclein transgenic rat model of Parkinson's disease
Journal of Molecular Neuroscience 2004
Citation only
The Role of α-Synuclein Assembly and Metabolism in the Pathogenesis of Lewy Body Disease
Journal of Neurochemistry 2016
Open access · OA
Therapeutic approaches in Parkinson's disease and related disorders
npj Parkinson s Disease 2024
Open access · CC-BY
Cell-to-cell transmitted alpha-synuclein recapitulates experimental Parkinson’s disease
Aktuelle Neurologie 2007
Citation only